Literature DB >> 32279304

Further delineation of the female phenotype with KDM5C disease causing variants: 19 new individuals and review of the literature.

Virginie Carmignac1,2, Sophie Nambot1,3,4,5, Daphné Lehalle3, Patrick Callier1,4,5, Stephanie Moortgat6, Valérie Benoit6, Jamal Ghoumid7,8, Bruno Delobel9, Thomas Smol8,10, Caroline Thuillier10, Cécile Zordan11, Sophie Naudion11, Thierry Bienvenu12,13,14, Renaud Touraine15, Francis Ramond15, Christiane Zweier16, André Reis16, Cornelia Kraus16, Mathilde Nizon17, Benjamin Cogné17, Alain Verloes18, Frédéric Tran Mau-Them1,4, Arthur Sorlin1,3,4, Thibaud Jouan1, Yannis Duffourd1,5, Emilie Tisserant1,5, Christophe Philippe1,4, Antonio Vitobello1,4, Julien Thevenon1,3,5, Laurence Faivre1,3,4,5, Christel Thauvin-Robinet1,4,5,19.   

Abstract

X-linked intellectual disability (XLID) is a genetically heterogeneous condition involving more than 100 genes. To date, 35 pathogenic variants have been reported in the lysine specific demethylase 5C (KDM5C) gene. KDM5C variants are one of the major causes of moderate to severe XLID. Affected males present with short stature, distinctive facial features, behavioral disorders, epilepsy, and spasticity. For most of these variants, related female carriers have been reported, but phenotypic descriptions were poor. Here, we present clinical and molecular features of 19 females carrying 10 novel heterozygous variants affecting KDM5C function, including five probands with de novo variants. Four heterozygous females were asymptomatic. All affected individuals presented with learning disabilities or ID (mostly moderate), and four also had a language impairment mainly affecting expression. Behavioral disturbances were frequent, and endocrine disorders were more frequent in females. In conclusion, our findings provide evidence of the role of KDM5C in ID in females highlighting the increasing implication of XLID genes in females, even in sporadic affected individuals. Disease expression of XLID in females should be taken into consideration for genetic counseling.
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990KDM5C; X-linked intellectual disability; data-sharing; exome; females

Mesh:

Substances:

Year:  2020        PMID: 32279304     DOI: 10.1111/cge.13755

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  7 in total

Review 1.  Molecular and cellular events linking variants in the histone demethylase KDM5C to the intellectual disability disorder Claes-Jensen syndrome.

Authors:  Hayden A M Hatch; Julie Secombe
Journal:  FEBS J       Date:  2021-09-18       Impact factor: 5.542

Review 2.  Epigenetic genes and epilepsy - emerging mechanisms and clinical applications.

Authors:  Karen M J Van Loo; Gemma L Carvill; Albert J Becker; Karen Conboy; Alica M Goldman; Katja Kobow; Iscia Lopes-Cendes; Christopher A Reid; Erwin A van Vliet; David C Henshall
Journal:  Nat Rev Neurol       Date:  2022-07-20       Impact factor: 44.711

Review 3.  Frontotemporal degeneration genetic risk loci and transcription regulation as a possible mechanistic link to disease risk.

Authors:  Russell P Sawyer; Hillarey K Stone; Hanan Salim; Xiaoming Lu; Matthew T Weirauch; Leah Kottyan
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

4.  Caregiver-reported characteristics of children diagnosed with pathogenic variants in KDM5C.

Authors:  Hayden A M Hatch; Molly H O'Neil; Robert W Marion; Julie Secombe; Lisa H Shulman
Journal:  Am J Med Genet A       Date:  2021-06-04       Impact factor: 2.578

5.  Novel Variations in the KDM5C Gene Causing X-Linked Intellectual Disability.

Authors:  Po-Ming Wu; Wen-Hao Yu; Chi-Wu Chiang; Chen-Yu Wu; Jia-Shing Chen; Yi-Fang Tu
Journal:  Neurol Genet       Date:  2021-12-03

6.  E2F6/KDM5C promotes SF3A3 expression and bladder cancer progression through a specific hypomethylated DNA promoter.

Authors:  Kai-Long Liu; Yue-Wei Yin; Bao-Sai Lu; Ya-Lin Niu; Dan-Dan Wang; Bei Shi; Hong Zhang; Ping-Ying Guo; Zhan Yang; Wei Li
Journal:  Cancer Cell Int       Date:  2022-03-05       Impact factor: 5.722

7.  Loss of PHF6 leads to aberrant development of human neuron-like cells.

Authors:  Anna Fliedner; Anne Gregor; Fulvia Ferrazzi; Arif B Ekici; Heinrich Sticht; Christiane Zweier
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.